Getting Started

    Your Guide to Starting GLP-1 Medications

    Everything you need to know to begin your weight loss journey with GLP-1 medications safely and successfully.

    Beginning Your Weight Loss Journey

    Starting GLP-1 medications is an exciting step toward achieving your health goals. This comprehensive guide walks you through every stage of the process, from getting your initial prescription to understanding what to expect in your first weeks of treatment.

    Step 1
    Consultation & Eligibility
    Step 2
    Choose Your Medication
    Step 3
    Get Prescription
    Step 4
    Start Treatment

    Essential Guides for Beginners

    How to Get Prescribed GLP-1 Medications

    Step-by-step guide to getting a prescription for weight loss medications including eligibility requirements and consultation process.

    What to Expect: First Month on GLP-1s

    Detailed guide on what to expect during your first month, including side effects, dosing, and lifestyle adjustments.

    Choosing Between Semaglutide and Tirzepatide

    Compare the two leading medications to determine which might be the best fit for your weight loss goals.

    Finding the Right Healthcare Provider

    How to find a qualified healthcare provider who can prescribe and monitor your GLP-1 therapy.

    Am I Eligible for GLP-1 Medications?

    BMI Requirements

    Generally approved for individuals with BMI ≥30 kg/m² (obesity) or BMI ≥27 kg/m² (overweight) with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea.

    Medical Evaluation

    A healthcare provider will review your medical history, current medications, and perform necessary lab tests to ensure GLP-1 medications are safe and appropriate for you.

    Contraindications

    GLP-1 medications may not be suitable for individuals with personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, or severe gastrointestinal disease.

    Ready to Get Started?

    Begin your weight loss journey with Trimi. Our healthcare providers can evaluate your eligibility and guide you through every step of the process.

    Start Your Consultation

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    How do I get started on GLP-1 weight-loss treatment?

    Getting started on GLP-1 weight-loss treatment through a legitimate US telehealth provider takes 5–7 days end-to-end: complete an online health assessment (5–10 minutes), wait for board-certified clinician review (usually within 24 hours), prescription is dispatched to an FDA-regulated pharmacy if appropriate, pharmacy fulfills (1–2 days), expedited shipping arrives (2–3 days). Eligibility requires BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity. Once medication arrives, patients should review the dosing schedule, prepare an injection-site rotation plan (abdomen, thigh, upper arm), and pace meals smaller and more frequent during the first 2 weeks to manage tolerability.

    5–7 day end-to-end timeline through legitimate telehealth.
    Eligibility: BMI ≥30, or ≥27 with one comorbidity.
    Smaller, more frequent meals improve first-month tolerability.

    Key Takeaways

    • Starting GLP-1 weight-loss treatment involves: eligibility check (BMI threshold + clinical history), provider evaluation, prescription, pharmacy fulfillment, and shipped medication.
    • Standard timeline through a legitimate telehealth provider: 5–7 days from initial assessment to receiving the first dose.
    • Eligibility per FDA labeling: BMI ≥30 (obesity), or BMI ≥27 with at least one weight-related comorbidity.
    • First-dose preparation: room-temperature medication storage per label, prep injection site with alcohol wipe, follow injection-site rotation guidance.

    Medically Reviewed

    DMR

    Dr. Michael Rodriguez

    MD, FACP, Board Certified in Internal Medicine

    Internal Medicine & Weight Management

    Last reviewed: May 4, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Michael Rodriguez, MD, FACP, Board Certified in Internal Medicine

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    — Robyn Lynn CurtisFacebook
    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    — Sarah MillerFacebook
    See all community reviews →

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    3. The Endocrine Society (2024). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism.Read Study
    4. U.S. Food and Drug Administration (2026). BeSafeRx: Your Source for Online Pharmacy Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Comparisons

    First Time Getting GLP-1? Complete Beginner\

    Complete guide covering starting GLP-1 treatment for the first time in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active ingredients at u

    10 minRead More
    Retatrutide

    Retatrutide: Complete Guide

    Detailed comparison of retatrutide vs orforglipron: injectable triple agonist vs the first oral GLP-1 pill. Weight loss data, convenience, side effects, and which might be right for you.

    10 minRead More
    Guide

    First Month on Semaglutide: What to Expect

    Complete guide to your first month on semaglutide, including side effects timeline, weight loss expectations, and tips for success.

    12 minRead More
    Comparisons

    Weight Loss Injections for $99/Month: How to Get Started

    Complete guide covering affordable weight loss injection options in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active ingredients at up t

    10 minRead More

    Start your GLP-1 journey — from $99/mo

    Get Started